Market News AIOpen the app

Emergent BioSolutions is teaming up with Asimov to create treatments for Ebola using new technology.

DealRead the original at globenewswire.com
Good for EBS

The partnership gives Emergent a defined development program for 2 Ebola-targeting antibodies and access to Asimov's cell line system. No completed product or financial result is reported, but the work supports Emergent's preparedness efforts.

EBS · Emergent BioSolutions

AI read · Good for EBS

The AI's read

This gives Emergent access to Asimov's cell line system for work tied to Ebola protection. The project includes design and research-cell-bank production, but the announcement reports planned work, not a completed product or financial result.

Get alerts for EBS

Follow Emergent BioSolutions (EBS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for EBS
Free on the App Store and Google Play, or on the web.